Aktie CANNABIS SCIENCE INC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Cannabis Science Inc OTC Bulletin Board

Aktien

US1376481016

Schlusskurs OTC Bulletin Board
Andere Börsenplätze
- USD - Intraday Chart für Cannabis Science Inc
2023 GBX International Group Inc. stimmt der Ausgliederung von Cannabis Science, Inc. zu CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
GBX International Group Inc. agreed to Spin-Off Cannabis Science, Inc.
Cannabis Science Inc. Successfully Launches its $CSI Cannabis Science Coin for its CSi-EDP Utility Project Valuation Tracking
Thermic Sciences International signed a share exchange agreement to acquire Cannabis Science, Inc.
Canopy Growth : BC Centre on Substance Use hosts inaugural Cannabis Science Symposium
NHS Industries, Ltd. and Cannabis Science, Inc. Agree to Terminate the Previously Announced Joint Venture Agreement
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Partners With NHS Industries to Launch the CBIS CDN Economic Development Plan
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
Cannabis Science Successfully Moves Operations to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
Cannabis Science, Inc. Successfully Completes Lab Testing for Its Proprietary, Short-Time Vacuum Distillation Process for Distribution of Purified High CBDA and CBD Water-Soluble Powders and Extracts Internationally
Mr. Raymond C. Dabney Prepares Cannabis Science for the Next Level With Key Acquisitions Negotiated and Planned Mergers, a New Branding Splash, and a Black-Tie Dinner Awards Gala for the Ages
Cannabis Science Propels Cancer Clinical Trials, Appoints Cellular Cancer Specialist Dr. Sulma Mohammed, Professor of Cancer Biology, Purdue University, to the Company’s Scientific Advisory Board
Cannabis Science, Inc. Appoints Sulma Mohammed to its Scientific Advisory Board
GHC Summit at Harvard Medical School Announces Cannabis Science as Industry Partner in the Launch of the International Phytomedicines Institute at Harvard Medical School
Cannabis Science and Dana-Farber Cancer Institute Sign a New Research Agreement to Investigate Proprietary Extract From Justicia Plant
Cannabis Science, Inc. and Dana-Farber Cancer Institute, Inc. Sign New Research Agreement to Investigate Proprietary Extract from Justicia Plant
Cannabis Science Releases Clinical Drug-Development Pipeline as it Transitions Into Clinical Trials; Right on Time for the Upcoming Global Health Catalyst Summit at Harvard Medical School, May 24-26, 2019
Cannabis Science Expands Into Canadian Market With Wholly-Owned Subsidiary Cannabis Science Canada Inc., Commences Negotiations for Canadian Land, Licenses, and Expansion Capital
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. Aktie
  4. Aktie
  5. Nachrichten Cannabis Science Inc
  6. Andere Sprachen